NEW YORK--(BUSINESS WIRE)--In an expansion of the firm’s established healthcare research franchise, Jefferies announced today the addition of Andrew Fein as a Managing Director and Senior Equity Research Analyst covering Biotechnology companies. Mr. Fein has more than ten years of experience as an analyst following the Biotechnology industry.
